


# Hyperkalemia

**Potassium regulation**

-   **Internal K shift:** modulated by insulin, catecholamines, acid-base status
-   **Total body K elimination:** By kidney(95%) and gut (5%)

## Adverse effects of hyperkalemia

-   **Cardiac:** Peaked T, wide QRS, loss of P wave, sine wave; although V fib may be first cardiac manifestation.
-   **Neuromuscular:** Paresthesias,weakness
-   **Metabolic:** Mild hyperchloremic metabolic acidosis

## Treatment of hyperkalemia

**Cardiac membrane stabilization **
-   **Calcium:** Reduces threshold potential in myocytes; check to be sure not on digoxin
-   **Hypertonic saline:** Only for severe hyponatremia in setting of hyperkalemia

 **K redistribution**
-   **Insulin:** Drives K intracellularly and drops serum K level by 0.6 mmol/L
-   **Beta-agonist:** Drives K intracellularly and 10 mg albuterol drops serum K level by 0.6 mmol/L(20 mg --&gt; K drops by 1 mmol/L);effective in only 60% of patients

** K elimination via kidney/gut**
-   **Bicarbonate:** drives K out at distal nephron; best as infusion x 4-6 hrs
-   **Loop diuretic**
-   **Exchange resin** (sodium polystyrene sulfonate): case reports of colonic necrosis;constipating med and so combined with sorbitol; minimal benefit. 


<table>
  <tr>
    <th>Agent</th>
    <th>Dose</th>
    <th>Onset</th>
    <th>Duration</th>
    <th>Complication</th>
  </tr>
  <tr>
    <td colspan="5">**Membrane Stabilization**</td>
  </tr>
  <tr>
    <td><span class="drug">Ca gluconate 10%</span></td>
    <td>10 mL over 10 min</td>
    <td>immediate</td>
    <td>30-60min</td>
    <td>hypercalcemia</td>
  </tr>
  <tr>
    <td><span class="drug">Hypertonic 3% NaCl</span></td>
    <td>50cc IV push</td>
    <td>immediate</td>
    <td>unknown</td>
    <td>volume overload, hypertonicity</td>
  </tr>
  <tr>
    <td colspan="5">**Redistribution**</td>
  </tr>
  <tr>
    <td><span class="drug">Insulin</span></td>
    <td>10 units IVP with D50W</td>
    <td>20 min</td>
    <td>4-6 hr</td>
    <td>hypoglycemia</td>
  </tr>
  <tr>
    <td><span class="drug">Albuterol nebulized</span></td>
    <td>20mg/4cc over 10 min</td>
    <td>30 min</td>
    <td>2 hrs</td>
    <td>tachycardia</td>
  </tr>
  <tr>
    <td colspan="5">**Elimination**</td>
  </tr>
  <tr>
    <td><span class="drug">Loop diuretic</span></td>
    <td>furosemide 40-80 mg IV</td>
    <td>15 min</td>
    <td>2-3 hr</td>
    <td>volume depletion</td>
  </tr>
  <tr>
    <td><span class="drug">Sodium bicarbonate</span></td>
    <td>150 mmol/L IV</td>
    <td>hours</td>
    <td>infusion</td>
    <td>metabolic alkalosis, volume overload</td>
  </tr>
  <tr>
    <td><span class="drug">Kayexalate</span></td>
    <td>150-30 g</td>
    <td>>2 hrs</td>
    <td>4-6 hr</td>
    <td>variable efficacy</td>
  </tr>
  <tr>
    <td><span class="drug">Hemodialysis</span></td>
    <td></td>
    <td>immediate</td>
    <td>3 hrs</td>
    <td>arrhythmias</td>
  </tr>
</table>


## References

-   [Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008; 36:3246-51.](https://www.ncbi.nlm.nih.gov/pubmed/?term=18936701)
